Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 4:41 pm Purchase | 2024-12-19 | 13G | 89bio, Inc. ETNB | Deep Track Capital, LP | 6,477,949 5.410% | 4,477,949 (+223.90%) | Filing History |
| 2024-11-22 4:16 pm Sale | 2024-11-20 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital, LP | 6,000,000 4.820% | -220,265 (-3.54%) | Filing History |
| 2024-11-22 08:47 am Purchase | 2024-11-15 | 13G | Apellis Pharmaceuticals, Inc. APLS | Deep Track Capital, LP | 6,220,265 5.000% | 6,220,265 (New Position) | Filing History |
| 2024-11-14 10:19 am Sale | 2024-09-30 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital, LP | 0 0.000% | -3,710,412 (Position Closed) | Filing History |
| 2024-11-14 10:18 am Sale | 2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital, LP | 1,000,000 2.220% | -1,323,456 (-56.96%) | Filing History |
| 2024-11-14 10:00 am Sale | 2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital, LP | 1,553,996 3.920% | -2,095,730 (-57.42%) | Filing History |
| 2024-11-14 09:47 am Sale | 2024-09-30 | 13G | Verona Pharma plc VRNA | Deep Track Capital, LP | 25,440,200 3.910% | -7,492,192 (-22.75%) | Filing History |
| 2024-11-14 09:46 am Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 531,857 0.700% | -6,990,424 (-92.93%) | Filing History |
| 2024-11-14 09:45 am Sale | 2024-09-30 | 13G | Tourmaline Bio, Inc. TRML | Deep Track Capital, LP | 0 0.000% | -1,815,854 (Position Closed) | Filing History |
| 2024-11-14 09:44 am Sale | 2024-09-30 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital, LP | 1,000,000 1.970% | -1,184,440 (-54.22%) | Filing History |
| 2024-11-14 09:44 am Sale | 2024-09-30 | 13G | Silence Therapeutics plc SLN | Deep Track Capital, LP | 3,000,000 2.140% | -2,854,740 (-48.76%) | Filing History |
| 2024-11-14 09:42 am Sale | 2024-09-30 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 0 0.000% | -2,992,731 (Position Closed) | Filing History |
| 2024-11-14 09:41 am Sale | 2024-09-30 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital, LP | 674,833 2.240% | -1,369,674 (-66.99%) | Filing History |
| 2024-11-14 09:39 am Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital, LP | 0 0.000% | -224,246 (Position Closed) | Filing History |
| 2024-11-14 09:38 am Sale | 2024-09-30 | 13G | Orchard Therapeutics plc ORTX | Deep Track Capital, LP | 0 0.000% | -19,125,150 (Position Closed) | Filing History |
| 2024-11-14 09:36 am Sale | 2024-09-30 | 13G | HilleVax, Inc. HLVX | Deep Track Capital, LP | 0 0.000% | -2,900,000 (Position Closed) | Filing History |
| 2024-11-14 09:31 am Sale | 2024-09-30 | 13G | Geron Corporation GERN | Deep Track Capital, LP | 7,575,049 1.260% | -22,008,400 (-74.39%) | Filing History |
| 2024-11-14 09:29 am Sale | 2024-09-30 | 13G | Climb Bio, Inc. CLYM | Deep Track Capital, LP | 2,169,143 3.230% | -1,735,642 (-44.45%) | Filing History |
| 2024-11-14 09:27 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital, LP | 3,282,000 3.270% | 1,282,000 (+64.10%) | Filing History |
| 2024-11-14 09:24 am Sale | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 0 0.000% | -2,036,990 (Position Closed) | Filing History |